Global Initiative for Asthma 2016-derived Asthma Control With Fluticasone Propionate and Salmeterol: A Gaining Optimal Asthma Control (GOAL) Study Reanalysis - Université de Montpellier
Article Dans Une Revue Annals of Allergy, Asthma and Immunology Année : 2019

Global Initiative for Asthma 2016-derived Asthma Control With Fluticasone Propionate and Salmeterol: A Gaining Optimal Asthma Control (GOAL) Study Reanalysis

Résumé

Background: In 2004, the landmark Gaining Optimal Asthma Control (GOAL) study demonstrated that most patients can achieve asthma control through sustained treatment and that adding a long-acting β2-adrenoreceptor agonist to an inhaled corticosteroid (ICS) is more effective than ICS alone in this regard. Definitions of asthma control have since evolved, and the consequent implications for the GOAL study findings are unclear. Objective: To evaluate the efficacy of fluticasone propionate and salmeterol and fluticasone propionate alone in achieving and maintaining asthma control, as derived from the Global Initiative for Asthma (GINA) 2016 report. Methods: In total, 3416 patients were stratified by prior medication (ICS-naive [stratum 1], low-dose ICS [stratum 2], or medium-dose ICS [stratum 3]) and randomized to receive fluticasone propionate and salmeterol or fluticasone propionate. The primary end point was the proportion of patients achieving well-controlled or partly controlled asthma; secondary end points included the proportion of patients achieving well-controlled asthma. Control was evaluated during the last 4 weeks of each dose titration. Results: In all strata, more patients achieved well-controlled or partly controlled asthma with fluticasone propionate and salmeterol vs fluticasone propionate alone (stratum 1: 91% vs 85%; P = .003; stratum 2: 86% vs 82%; P = .07; and stratum 3: 76% vs 66%; P < .001), as well as patients with well-controlled asthma (stratum 1: 64% vs 56%; P = .005; stratum 2: 59% vs 41%; P < .001; and stratum 3: 40% vs 22%; P < .001). Conclusion: A markedly higher proportion of patients with uncontrolled asthma in each stratum achieved control according to GINA 2016 criteria compared with the original study criteria. The proportion of patients achieving control remained greater with fluticasone propionate and salmeterol than with fluticasone propionate alone.
Fichier principal
Vignette du fichier
PIIS1081120619303175.pdf (944.65 Ko) Télécharger le fichier
Origine Publication financée par une institution
Loading...

Dates et versions

hal-02862409 , version 1 (09-06-2020)

Identifiants

Citer

Eric D. Bateman, William Busse, Søren E. Pedersen, Jean Bousquet, Shaoguang Huang, et al.. Global Initiative for Asthma 2016-derived Asthma Control With Fluticasone Propionate and Salmeterol: A Gaining Optimal Asthma Control (GOAL) Study Reanalysis. Annals of Allergy, Asthma and Immunology, 2019, 123 (1), pp.57--63.e2. ⟨10.1016/j.anai.2019.04.018⟩. ⟨hal-02862409⟩
41 Consultations
88 Téléchargements

Altmetric

Partager

More